// App-Quantinova.ai

154 : Changes in the use of commercial and lab-developed IVD assays in the clinical setting for PD-L1 expression testing in NSCLC in the United States.

Researchers

Presenter

  • Ayse Levent

Principal Investigators

  • Pieter De Richter

  • William H Angel

  • Ciny Edathanal

  • Christophe Homer

Medical Centers

  • Ipsos Healthcare, New York, NY

  • Ipsos Healthcare, Kuala Lumpur, Malaysia

  • Ipsos Healthcare, London, United Kingdom

Locations

  • United States

  • Malaysia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved